Quintiles designates Comprehensive with Prime Site status
Wednesday, September 26, 2012
CRO Quintiles has designated Comprehensive Clinical Development, a Miramar, Fla.-based clinical research company, as a Quintiles Prime Site—a distinction that gives Comprehensive an enhanced role in global clinical research and testing of new and more effective medicines.
As a Quintiles Prime Site, Comprehensive has access to new industry-sponsored clinical trials through Quintiles. Comprehensive joins a group of sites across North and South America, Europe, Africa and Asia, and is the first non-academic, non-hospital based organization awarded this status.
“Comprehensive’s dedication to timeliness and quality, combined with their strong patient relationships and delivery quality, will enhance our ability to recruit patients quickly and efficiently to provide greater value for our customers,” said Lindy Jones, senior vice president, integrated site services, Quintiles. “We look forward to a successful relationship with Comprehensive.”